A Study of Second- and Later-line Palliative Chemotherapy in Patients With Metastatic Colorectal Cancer.

NCT07263178 · clinicaltrials.gov ↗

RECRUITING

Status

1000

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Second and later-line palliative chemotherapy

Sponsor

Boryung Pharmaceutical Co., Ltd